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STUDY OUTLINE 
 
This master’s dissertation is presented in manuscript format, with two studies and five chapters; Chapter 
1: background/literature review, Chapter 2: manuscript 1, Chapter 3: manuscript 2, Chapter 4: synthesis 
and conclusions. Chapter 5: appendices. The abstract states the aims and main findings of this study. 
Chapter one is a detailed literature review which discusses what is known about autism, the gaps that 
may exist in the knowledge of autism and how the current study aims to fill in those gaps. Chapter two 
contains the first manuscript which focuses on the effects of prenatal exposure to valproic acid. This 
manuscript will be submitted to the International Journal of Developmental Neuroscience and is written 
in accordance to the journal guidelines. Chapter three contains the second manuscript which focuses on 
the effects of maternal separation stress with prenatal exposure to valproic acid. Chapter four is a 
synthesis which identifies the link between the two studies and concludes the overall findings. Chapter 
five contains additional appendices including ethical approval, protocols used in this study and 
conference output. 
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ABSTRACT 
 
Autism Spectrum Disorders (ASD) are a category of neurodevelopmental disorders that have become 
more prevalent, causing much concern. Autistic individuals display symptoms ranging from repetitive 
behaviours to communication deficiency and impaired executive function. There are numerous risk 
factors for autism including exposure to particular medications, like valproic acid (VPA), and certain 
environments. VPA has been shown to increase the risk of autism in unborn children. Furthermore, early 
stressful events like maternal deprivation are known to have a part in causing neurodevelopmental 
disorders.  Therefore, in this study we used VPA to induce autism and aimed at investigating how VPA 
alters the major neurotransmitter system pathways, which results in autistic-like behaviour. 
Furthermore, we conducted maternal separation to investigate the effect of stress together with VPA. 
 
This study used forty-eight Sprague-Dawley rat pups which were divided in to control (saline-0.9%, 3.3 
ml/kg), VPA (VPA-500 mg/kg) and stressed groups. Maternal separation stress was conducted for 12 
days. The novel-object recognition test and open field test were conducted to assess the pup’s behaviour. 
PCR was conducted to measure the expression of GABA receptors in the hippocampus and cerebellum. 
The concentrations of glutamate, serotonin transporter and corticosterone were assessed in the prefrontal 
cortex, hippocampus, amygdala and blood.  
 
Exposure to VPA resulted in decreased glutamate concentrations in the hippocampus and prefrontal 
cortex whilst it caused an increase in hippocampal GABBR1, GABRB3 and cerebellum GABRB3, but 
a decrease in the cerebellum GABBR1. These alterations were accompanied by repetitive and 
hyperactive behaviour, seen in the open field test whilst memory deficits were observed in the novel 
object recognition test. Exposure to maternal separation stress and VPA caused a dysfunction in the 
stress response which lead to a decrease in corticosterone concentration. Maternal separation stress and 
VPA exposure also decreased the serotonin transporter concentration in the amygdala and prefrontal 
cortex. These alterations were accompanied by anxiety-like behaviours, seen in the open field test where 
we observed a decrease in the time spent in the centre and the total excretion. 
 
This study shows that exposure to VPA alters neurotransmitter balance thus resulting in an autistic-like 
phenotype. Furthermore, exposure to maternal separation stress and VPA causes a desensitization in the 
stress response. 
 
Key words: Autism, valproic acid, maternal separation stress, neurotransmitters, behaviour  
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CHAPTER ONE  
Chapter one consists of a brief background on the overall topic, states the research objectives/aims and 
includes a literature review which covers the knowledge known about autism as well as identifies the 
gaps we aim to fill.  
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Introduction  
Autism is a neurodevelopmental disorder characterized by restricted, repetitive behaviours, decreased 
social cooperation and communication deficiency (Lord et al., 2000, Frith and Happé, 2005). These 
impairments vary greatly hence the term Autism Spectrum (ASD) was developed to acknowledge this 
diversity (Faras et al., 2010). The autism spectrum ranges from Asperger’s syndrome, Kanner’s 
syndrome, childhood disintegrative disorder, nonspecific pervasive developmental disorder and Rett’s 
syndrome (Hrabovska and Salyha, 2016). ASD commonly develops during infancy or in the first years 
of life (Lord et al., 2000).  
 
Dysfunction in the major neurotransmitter systems, like the GABAergic, glutamatergic and serotonergic 
systems, are linked to the pathogenesis of ASD (Trottier et al., 1999, Kwong et al., 2000, Cetin et al., 
2015). Gamma aminobutyric acid (GABA) is essential in many processes like stages of maturation and 
early developmental stages of cell migration (Ben-Ari et al., 2012). Whilst glutamate is a principal 
excitatory neurotransmitter (Cetin et al., 2015). Serotonin plays an important role in many processes, 
including emotional states plus sexual behaviour, and is essential for the development of social skills 
(Buhot et al., 2000, Whitaker-Azmitia, 2001, Brummelte et al., 2017). Therefore, these systems have 
important roles in many neurodevelopmental disorders, including ASD (Coghlan et al., 2012, Cetin et 
al., 2015).    
 
The global prevalence of autism in the 1960’s was around 4 per 10,000 (Frith and Happé, 2005). 
However, in 2018 it had increased to 1 in 59 children (Baio et al., 2018). Evidence suggests that Autism 
Spectrum Disorders are caused by genetics and are one of the heritable disorders, however the risk of 
developing ASD’s can be influenced by environmental factors (Frith and Happé, 2005, Faras et al., 
2010, Dietert et al., 2011, Hrabovska and Salyha, 2016). 
 
Direct exposure to particular drugs, stress, environmental chemicals and dietary factors are 
environmental risk factors for autism (Dietert et al., 2011). In addition, exposure to pharmacological 
agents like valproic acid (VPA) and thalidomide are very current environmental risk factors (Dietert et 
al., 2011). There are conditions that can increase the susceptibility of autism, through exposure during 
the prenatal, perinatal and neonatal periods (Baron-Cohen and Bolton, 1993, Guinchat et al., 2012). 
During pregnancy stress and medication are considered to be risk factors of autism (Gardener et al., 
2009, Guinchat et al., 2012). 
 
During a stress event, the hypothalamic-pituitary-adrenocortical (HPA) axis is activated, as it is essential 
in controlling biological processes, like responding to stress (Corbett and Simon, 2014). Cortisol is the 
main stress hormone in humans which is released when the HPA axis is triggered (Corbett and Simon, 
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2014). Premature harmful experiences like disrupting the maternal-offspring bond results in life long 
consequences (Vetulani, 2013). Maternal separation is a form of early life stress that has been  associated 
with the development of neurological disorders and therefore the maternal separation stress model is 
used to investigate the effects of premature trauma (Weiss et al., 2011, Mpofana et al., 2016). 
 
There are several groups of autism animal models, including pre/postnatal exposure to particular  
environmental factors which replicates the main symptoms of autism (Hrabovska and Salyha, 2016). 
VPA is clinically used in treating epilepsy however, it’s usage during pregnancy has become concerning 
as it has been linked with the risk of autism (Mabunga et al., 2015). Hence, prenatal exposure to VPA 
is used in investigations to create autism animal models (Mabunga et al., 2015). 
 
Literature Review 
Autism 
Pervasive developmental disorders are a set of neurodevelopmental disorders characterized by 
impairments in reciprocal social interaction, communication and restricted repetitive interests or 
behaviours (Faras et al., 2010). One of these neurodevelopmental disorders are known as autism (Faras 
et al., 2010). Autism is characterized by impaired social reciprocity, deficits in communication and by 
abnormal repetitive, restricted behaviours and interests  (Lord et al., 2000, Frith and Happé, 2005). The 
display of these impairments varies in severity and range with age and ability, thus the concept of the 
autism spectrum was brought about to acknowledge this heterogeneity (Frith and Happé, 2005, Faras et 
al., 2010). Autism spectrum disorders (ASD) is the term commonly used to describe this variation in 
impairments (Faras et al., 2010). In the most severe cases, symptoms such as evading eye contact, little 
to no social interaction with peers, inability to understand and explain other’s feelings and social cues, 
neglect in developing peer relationships, absence of seeking to share enjoyment, lack in reciprocating 
emotion, as well as awkward and even complete absence of speech (Arruda, 2017). Dysfunction in the 
neurotransmitter systems is considered to be the reason for ASD, through affecting synaptogenesis, 
differentiation, neuronal cell migration and lastly the developmental processes of the brain (Kwong et 
al., 2000, Cetin et al., 2015). The GABAergic, glutamatergic and serotonergic neurotransmitter systems 
are the main systems associated with the pathogenesis of ASDs (Trottier et al., 1999). Studies have 
observed a reduction in GABAB and GABAA receptor subunits in several brain regions which 
substantiates the extensive dysfunction of the GABAergic system in patients with ASD (Rolf et al., 
1993, Fatemi et al., 2009b, Oblak et al., 2010). Changes in the expression of GAD65/67 and GABA 
receptor subunits have been documented to result in alterations in the excitatory/inhibitory equilibrium 
in the brain which cause many cognitive impairments linked with autism (Fatemi et al., 2010). Several 
studies confirm the theory of “decreased GABAergic transmission in ASD patients” (Fatemi et al., 
2009b, Oblak et al., 2010). Gamma-aminobutyric acid receptor subunit beta-3 (GABRB3) and Gamma-
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aminobutyric acid type B receptor subunit 1 (GABBR1) deficiencies in autism has been shown to cause 
impairments in memory, exploratory and social behaviour (DeLorey et al., 2008, Fatemi et al., 2009b, 
Fatemi et al., 2010). Alterations in the glutamatergic system is crucial as disruptions impair cognitive 
functions like memory and have been associated with repetitive and restricted behaviours (Carlsson, 
1998, Jamain et al., 2002, Koppers, 2010, Cetin et al., 2015, Horder et al., 2018). ASD patients 
experience dysfunctions in the serotonergic systems (Cetin et al., 2015). Serotonin is essential in the 
development of social skills during early developmental periods and inadequate stimulation of serotonin 
in the premature stages of life can result in unpreventable abnormalities in serotonin metabolism 
(Brummelte et al., 2017, Cetin et al., 2015). The autism disorder typically develops in infancy or at 
latest in the first three years of existence (Lord et al., 2000). Parents become concerned once they notice 
differences in their child including the lack of utilizing words to communicate, addressing their parents 
by name, pointing to objects that they find interesting and not seeking the company of others when they 
feel happy (Lord et al., 2000). In addition, Lord et al. (2000) documented that repetitive behaviours like 
specific hand movements as well as using the peripheral vision to look at wheels or lines can be observed 
in the preschool years of autistic children.  
 
The Autism Spectrum 
This heterogenous disorder includes Asperger’s syndrome, Kanner’s syndrome, childhood 
disintegrative disorder, nonspecific pervasive developmental disorder and Rett’s syndrome (Hrabovska 
and Salyha, 2016). Patients with Asperger syndrome (AS) display similar symptoms to patients with 
autism including improper communication skills, restriction in interests and lack in social interaction 
(Barahona-Corrêa and Filipe, 2015). However, AS patients exhibit a wide variety of understated clinical 
characteristics which differentiate AS from autism (Barahona-Corrêa and Filipe, 2015). Complications 
in distinguishing AS from autism and problems with operationalising diagnostic criteria, eventually 
resulted in its merging in-to the combined category of ASD (Barahona-Corrêa and Filipe, 2015). 
Furthermore, according to Pearce (2005) communication impairment represents a diagnosis of autism 
and  not Asperger’s disorder. A psychiatrist named Leo Kanner, noted that in nearly all the cases the 
infant’s behaviour was unusual from early infancy which he referred to as ‘‘early infantile 
autism’’(Kanner, 1943, Kanner, 1944, Pearce, 2005). Therefore, he proposed a probable genetic, inborn 
defect (Kanner, 1943, Kanner, 1944, Pearce, 2005). Whilst Rett’s Syndrome and Childhood 
Disintegrative Disorder, commonly known as Heller’s Syndrome, are identified by developmental 
regression with extreme autistic features (Barahona-Corrêa and Filipe, 2015). Furthermore, there is a 
category known as the nonspecific pervasive development (PDD-NOS), which is utilized in cases of 
pervasive impairment in communication and social interaction with the appearance of stereotyped 
behaviours or interests whenever specifications for a specific disorder are not met (Lord et al., 2000).  
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Epidemiology 
In the 1960s, when the first systematic studies on autism were conducted, the prevalence approximation 
was roughly 4 per 10,000 (Frith and Happé, 2005). However, in the modern world ASD’s are global and 
the approximation, in the year 2005, for the entire autism spectrum was roughly 60 per 10,000 (Frith 
and Happé, 2005). This 15-fold elevation has caused the fear of an epidemic. For example, during 2011–
2012 in the United States various ASD’s were officially detected in approximately 2% of school children 
(Arruda, 2017). In addition, the statistics from the Centres for Disease Control and Prevention (CDC) s 
illustrates just how prevalent autism has become in the recent years, shown in Figure 1 (Baio et al., 
2018). 
 
 
Figure 1: The estimated prevalence of autism in 2018 was according to the Centre’s for Disease 
Control and Prevention (Autism Speaks, 2018) 
 
According to the statistics of Autism South Africa, autism affects 1 in 110 children internationally whilst 
a staggering amount of 7665 autistic children are born in South Africa annually (Autism South Africa). 
This further indicates that 160 autistic children are born weekly and 23 autistic children daily, which 
essentially means that virtually one child with autism is born every hour (Autism South Africa). 
 
However, according to Frith and Happé (2005) the diagnostic criteria have evolved substantially over 
the years and therefore only a small percentage of the present spectrum would have satisfied the 1960s 
criteria. In addition, the rise in the prevalence of identified autistic cases may be a result of the expansion 
of diagnostic criteria, diagnostic facilities or specialist provision as well as a significant increase in 
awareness (Frith and Happé, 2005).  
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Risk Factors 
Currently there is no general agreement with regard to the causes or risk factors that result in the 
development of ASDs (Hrabovska and Salyha, 2016). 
 
There is evidence which indicates that ASD is a result of genetics (figure 2), because it is associated 
with changes in the interaction of numerous genes as well as spontaneous mutations (Hrabovska and 
Salyha, 2016). Autism is familial and one of the most heritable developmental disorders, as the 
prevalence of autistic features and ASD is greater in siblings of autistic patients, and members of their 
families are 50 more times likely to have ASD than the general community (Frith and Happé, 2005, 
Faras et al., 2010, Hrabovska and Salyha, 2016). Frith and Happé (2005) also observed a much higher 
concordance in identical twins compared to fraternal twins. Furthermore, interferences in brain 
development can be a result of defects in the genes that are responsible for such development and 
premature brain cell communication (Arruda, 2017). According to Autism South Africa and Faras et al. 
(2010) ASD is 4 - 5 times more prevalent in males than females.  
 
Figure 2 : The common environmental and genetic risk factors for autism (Gadad et al., 2013) 
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Autism is a developmental disorder hence sensitive periods of developmental vulnerability occurs 
according to the period that the risk factor is exposed, namely: prenatal, perinatal and neonatal (Dietert 
et al., 2011, Guinchat et al., 2012). 
 
Guinchat et al. (2012) recorded advanced paternal age, advanced maternal age and primiparous women 
to be familial risk factors for autism. It is possible that maternal age and autism maybe be associated as 
a result of an increase in the risk of chromosomal abnormalities in ova due to increased age or unstable 
trinucleotide repeats (Gardener et al., 2009).  Reichenberg et al. (2006) proposed that paternal age and 
autism maybe be associated as a result of de novo spontaneous mutations, imprinted genes which 
increase with the advance in the spermatogonia’s age or confounding through sociocultural 
environmental components. A common risk factor for autism in literature is birth parity/ order, however 
this relationship is inconsistent as it may be as a result of possible effect modifications by sibship size 
(Gardener et al., 2009).  
 
Exposure to certain environmental factors pose a risk for autism, as shown in figure 2 above (Dietert et 
al., 2011). The environment can potentially cause ASDs as there are indications that exposure to 
dangerous substances, have prenatal effects and have been found to be contributing factors in the 
development of autism (Dietert et al., 2011, Hrabovska and Salyha, 2016, Arruda, 2017). However to 
Baron-Cohen and Bolton (1993) it appeared that there isn’t an environmental trigger of ASD, but rather 
conditions that make an individual susceptible to autism. 
 
Medication, stress and bleeding during pregnancy were identified as risk factors with regards to the 
pregnancy (Gardener et al., 2009, Guinchat et al., 2012). Neurotoxicants, like arsenic, lead, manganese 
plus mercury, are regarded as risk factors for autism as they disrupt neural development and an increase 
in their environmental concentrations in the recent years parallels the increased prevalence of autism 
(Dietert et al., 2011). Exposure to particular pharmacological agents such as valproic acid (VPA) and 
thalidomide since the changing trends in the accessibility of certain drugs corresponds to the changing 
prevalence in autism (Dietert et al., 2011). VPA is a mood stabilizer and anti-convulsant, however usage 
of this medication during pregnancy has been linked to the risk of autism as it is a human teratogen 
(Ornoy, 2009, Roullet et al., 2013). Exposure to VPA has been documented to result in autistic-like 
behaviours in the progeny, including repetitive behaviours, deficits in communication and social 
behaviour (Roullet et al., 2013). On the other hand, infections and vaccines have been extensively 
researched as being risk factors for autism as it is presumed that if the offspring is exposed to bacterial 
or viral infections in utero, then neurodevelopment is influenced which can result in adverse outcomes 
(Dietert et al., 2011, Grabrucker, 2013). Getahun et al. (2017) documented that pregnancies involved 
with preeclampsia affects the placenta and as a result it undergoes morphological and histologic changes 
which impair placental function and this leads to foetal hypoxemia and chronic oxidative stress. Foetal 
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hypoxia, which is essentially oxygen deprivation during development, may be the root for the probable 
relationship between autism and gestational bleeding since hypoxia results in an increase in 
dopaminergic activity which is also evident in autistic individuals (Gillberg et al., 1995, Gardener et al., 
2009). Exposure to prenatal stress has been linked to increased risk in autism and has been found to 
result in key symptoms of autism, like impaired social interaction and cognitive deficits (Kinney et al., 
2008). In addition, other pregnancy-related factors including  prolonged labour, maternal hypertension, 
foetal distress, caesarean delivery, low Apgar score and cord complications are considered to be related 
to hypoxia and associated with autism risk (Gillberg et al., 1995). 
 
The main risk factors for autism in the perinatal period are a planned caesarean section, breech 
presentation and preterm birth, whilst birth defects, encephalopathy, hyperbilirubinemia, poor birth 
conditions like hypoxia/ low Apgar scores and low birth weight (LBW) are neonatal risk factors 
(Guinchat et al., 2012). Class et al. (2014) found that maternal bereavement stress postnatally is also 
linked to the increased risk of autism in the offspring. 
 
Stress and The HPA Axis 
Stress occurs in several forms which include psychological, infectious, physical and oxidative (Dietert 
et al., 2011). Both perceived and actual threats can activate the primary stress system (Corbett and 
Simon, 2014). Stress is the physiological reaction in response to an occurrence by the primary stress 
systems, like the hypothalamic-pituitary-adrenocortical (HPA) axis, being activated (Corbett and Simon, 
2014). The HPA axis is responsible for regulating numerous biological processes, with one of them 
being the response to severe psychological and physiological stress (Corbett and Simon, 2014).  
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Figure 3: How the Hypothalamic-Pituitary-Adrenal (HPA) axis works in response to stress (Xiao, 
2015) 
When the HPA axis is activated (Figure 3) the adrenal cortices are stimulated to secrete glucocorticoids 
(corticosterone in rats and mice and cortisol in humans), which is crucial in adapting to stress (Aguilera, 
2011, Corbett and Simon, 2014). These glucocorticoids establish necessary changes in the 
neuromodulators and metabolism to manage with challenges by responding to stressful situations and 
returning to homeostatic conditions quickly (Aguilera, 2011, Stephens and Wand, 2012).  
 
The activation of the HPA axis during acute stress is compulsory for adaptation to stressful situations 
whilst in chronic stress exorbitant exposure to constant elevated levels of stress hormones result in 
pathological consequences (McEwen, 1998, Aguilera, 2011, Dunlavey, 2018). Prolonged exposure to 
stress hormones can result in the predisposition of immune, metabolic and psychological alterations 
hence it is essential for the stress response to end to prevent adverse effects as a result of altered levels 
of glucocorticoids and corticotropin releasing hormone (Aguilera, 2011). The effects of chronic stress 
are displayed in reduced immune health and neurodegenerative brain disease (Dunlavey, 2018). 
Activation of the HPA axis through chronic stress can lead to several forms of HPA axis dysregulation 
including: adrenal exhaustion, sensitized stress responses and chronic basal hypersecretion (Thomas and 
Lena, 2010, Herman et al., 2011). Chronic stressors can cause a shift in the HPA axis from being over-
responsive to under-responsive or non-responsive (“adrenal fatigue”) and this adaptation of the HPA 
axis is believed to be a protective measure to survive, by preventing chronically increased cortisol levels 
from subduing immune function (Thomas and Lena, 2010). Furthermore, a state of hypo-cortisolism has 
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been observed in patients who experienced traumatic premature life events and chronic exposure to 
stressful environments (Thomas and Lena, 2010). 
 
The first 2 weeks of life is crucial in mammals, as this is the period during which the stress system is 
developed and is therefore referred to as the stress-hyporesponsive period (Lai and Huang, 2011, 
Schmidt, 2019). The stress-hyporesponsive period is defined by the reduction in adrenocortical 
glucocorticoid secretion after stressful events (Schmidt, 2019). The development of the stress system is 
essential in moulding its function for adulthood which influences the vulnerability to disorders related 
to stress and  resilience to stress in the future years (Schmidt, 2019). Early life stress during the period 
results in dysregulation of the HPA axis, modification in brain functioning and neurobehavior (Lai and 
Huang, 2011, Mpofana et al., 2016). Stress and trauma has been documented as a risk factor for co-
occurring plus exacerbating autism symptoms (Fuld, 2018). Chauhan et al. (2004) found that alterations 
in ceruloplasmin and transferrin regulation in autistic individuals resulted in irregular copper and iron 
metabolic processes which increased oxidative stress and therefore possibly played a role in autism. 
Ploeger et al. (2010), contended that the disturbance of early developmental events (20-40 gestational 
days in humans) maybe a route to infantile autism. Mueller and Bale (2008), documented that an early 
stress experience in prenatal development may cause patterns of male orientation in neurodevelopmental 
disorders. Jones et al. (2010) proposed that when prenatal stress is combined with maternal genotypic 
variations can result in the offspring having an autistic phenotype.  
 
Maternal Separation Stress 
New-born mammals are nurtured and protected by their mothers hence they remain within close range 
for some time (Sullivan et al., 2011, Vetulani, 2013). The first few days of life are necessary as complex 
interactions occur which are associated with nursing and plays an essential part in the cognitive and 
emotional development of the children (Sullivan et al., 2011, Vetulani, 2013). Detrimental early life 
events, including disturbances in the maternal-offspring bond, lead to long-lasting effects and result in 
acute disruptions (Nishi et al., 2014). These effects evolve due to the continuous activation of stress 
mediators like catecholamines and glucocorticoids, known as the allostatic load (Vetulani, 2013). This 
allostatic load has an effect on the neurochemistry and behaviour throughout the mammal’s lifetime and 
the outcomes of an uncontrolled load on an animal’s behaviour can be regarded as models for diseases 
(Howell and Sanchez, 2011, Vetulani, 2013). Since near contact with the mother is significant, maternal 
separation in the early years leads to an intense reaction of despair and protest in the neonate which 
accelerates the allostatic load which then results in acute disruptions of neurohormonal and 
physiological functions which has crucial consequences for neurochemical characteristics and social 
behaviour in adulthood (Howell and Sanchez, 2011, Vetulani, 2013).  
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Maternal separation has been classified as a form of early life stress which has been reported to be 
responsible for altering the development of the neuronal circuitry which is linked to the development of 
neurodevelopmental disorders (Mpofana et al., 2016). The maternal separation (MS) stress paradigm 
has been utilized in rodent models to examine the long-term effects of early life trauma (Weiss et al., 
2011). This model, which involves maternal deprivation for a particular duration in the first two weeks 
of birth,  mimics neglect, early life deprivation and disturbs mother–infant interaction (Weiss et al., 
2011). This paradigm models early postnatal stress during the stress hypo-responsive period (Nishi et 
al., 2013). Maternal separation paradigms can range from separation for 180–360 minutes to deprivation 
for 24 hours (Nylander and Roman, 2013). Maternal separation once a day for 3 hours or more during 
the first two weeks following birth has been shown to cause exaggerated responses to stress later in life 
by the HPA axis, more anxiety-like behaviour plus disruption in cognition and behaviour (Bondar et al., 
2018). Weiss et al. (2011) documented MS paradigms that cause changes in the HPA axis response to 
stressful environments and result in depressive/anxiety-like behaviour (Weiss et al., 2011).  
 
Animal Models of Autism 
It is essential to research the causes and risk factors of ASD so that medication can be developed and 
strategies to manage the symptoms of these disorders can be introduced, this is the principal reason that 
animal models of autism are emerging (Hrabovska and Salyha, 2016). There are four groups of autism 
animal models, namely: (i) models that have neonatal impairments with abnormalities that are known 
to exist in the brain of individuals with autism (cerebellum, medial prefrontal cortex) (ii) models where 
animals that lack specific neuropeptide receptors (opioids, oxytocin, vasopressin receptors) (iii) genetic 
models, linked to the X-chromosome, which display autistic-like behaviours and alterations in the 
immune system (iv) models in which there is exposure to  environmental factors which increase the 
probability of autism in humans (Thalidomide and Valproic Acid) (Gadad et al., 2013, Hrabovska and 
Salyha, 2016). 
 
Substances like 5-methoxytryptamine, thalidomide and valproic acid (VPA) are utilized to create autism 
models, seen above in group iv, as they can possibly cause epigenetic modifications (Gadad et al., 2013, 
Mabunga et al., 2015). According to Mabunga et al. (2015), the number of researchers using the prenatal 
VPA exposure animal model has increased in the last decade due to it its versatility and its powerful 
etiologic relevance. 
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Figure 4: The validity of the VPA animal model (Mabunga et al., 2015) 
 
This usage of VPA is of concern because for many years, it was affiliated with several teratogenic effects 
(figure 4) and, more recently, increased risk of autism (Gottfried et al., 2013, Mabunga et al., 2015, 
Ornoy et al., 2019). Thus clinical findings which have been reported, have resulted in a series of pre-
clinical investigations utilizing VPA to induce autism-like responses in mice and rats (Mabunga et al., 
2015). 
 
Purpose 
Gray (1993) deduced from his study that autism has a unique stigma attached to it, due to the lack of 
public awareness and comprehension regarding autism, the typical physical appearance of children with 
autism and the disorderly nature of autistic symptoms. Particularly, the rural communities encounter 
significant challenges regarding availability of support services, treatment and diagnoses for those with 
ASD (Antezana et al., 2017). This ultimately results in the possibility for delayed screening and 
diagnosis of ASD therefore producing lower functional and educational outcomes (Antezana et al., 
2017). The authors of this study hope their papers will be read by the community to bring about more 
awareness and to educate people on ASD. 
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Aims 
The focus of this study was to: 
• Investigate how VPA alters the major neurotransmitter system pathways, that result in autistic-
like behaviour 
• Determine the effects of early life stress on the VPA rat model of autism 
 
Objectives 
The research objectives for the purpose of this project were:  
• To induce Autism in the offspring by injecting the pregnant rats with VPA  
• To induce early postnatal stress through exposure of maternal separation 
• To assess behavioural and neurochemical changes associated with VPA and Maternal separation 
exposure  
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CHAPTER TWO 
 
 
 
Manuscript 1 
 
 
 
This manuscript will be submitted to the Journal of International Developmental Neuroscience. 
The manuscript consists of a brief introduction highlighting autism, a detailed materials and methods 
section followed by the results and discussion sections. This manuscript was written in a submission 
format according to the authors guidelines for the journal. This paper focuses on how Valproic acid 
alters the neurotransmitter system to cause autistic-like behavior.  
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ABSTRACT 
Introduction: Autism is a neurodevelopmental disorder which is one of the crucial health care issues. 
This disorder is characterized by impaired social reciprocity, deficits in communication and by abnormal 
repetitive, restricted behaviours and interests which have been linked to alterations in the glutamatergic 
system and changes in the expression of GABA receptor subunits. Autism is primarily known as a 
genetic disorder, however there are numerous environmental risk factors that have been reported, 
including the exposure to certain drugs or medications such as the anti-convulsant Valproic acid, has 
been affiliated with several teratogenic effects and an increased risk in autism, when used during 
pregnancy. The aim of this study was to investigate how VPA alters the major neurotransmitter system 
pathways, to induce autistic-like behaviour. 
Methods: This study used twenty-four rat pups which were divided in to control (saline-0.9%, 3.3 ml/kg) 
and experimental (VPA-500 mg/kg) groups. The novel-object recognition test and open field test were 
conducted to assess the pup’s behaviour. A Glutamate assay and PCR was conducted to measure the 
glutamate concentration and expression of GABA receptors. 
Results: Exposure to VPA caused a significant decrease in the glutamate concentration in the 
hippocampus and prefrontal cortex while it resulted in a significant increase in GABRB3 in the 
hippocampus and increasing tendency in the cerebellum. Furthermore, VPA caused an increasing 
tendency in hippocampal GABBR1, but a decreasing tendency in the cerebellum. These alterations were 
accompanied by repetitive behaviour, hyperactivity and memory deficits. 
Conclusion: This study showed that valproic acid causes autistic-like behaviour by altering the 
glutamatergic and GABAergic neurotransmitter systems thus replicating the autistic-like phenotype. 
Key Words: Pervasive developmental disorders, Autism, Valproic acid, glutamate,  
                     GABA 
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INTRODUCTION 
Pervasive developmental disorders (PDD) are amongst the most common neurodevelopment disorder 
globally (Faras et al., 2010). One group of these neurodevelopmental disorders is well known as autism,  
autism forms one of the crucial health care issues (Faras et al., 2010, Hrabovska and Salyha, 2016). 
Autism is characterized by impaired social reciprocity, deficits in communication and abnormal 
repetitive, restricted behaviours and interests  (Lord et al., 2000, Frith and Happé, 2005). The autism 
spectrum (ASD) acknowledges the variety in the display of impairments seen in autism (Frith and 
Happé, 2005, Faras et al., 2010). Executive function issues are commonly observed throughout the 
spectrum (Barendse et al., 2013). Severe cases of autism experience symptoms like evading eye contact, 
complete absence of speech and even hyperactivity as ASD commonly overlaps with Attention deficit 
hyperactivity disorder  (Liao et al., 2016, Arruda, 2017). Studies have shown that a deficiency of GABA 
receptors , including GABRB3/GABBR1, in autism can result in memory impairments plus changes in 
social and exploratory behaviour (DeLorey et al., 2008, Fatemi et al., 2009b, Fatemi et al., 2010). 
Furthermore, changes in the glutamatergic system have been documented to impair cognition and play 
a role in repetitive behaviours (Carlsson, 1998, Jamain et al., 2002, Koppers, 2010, Cetin et al., 2015, 
Horder et al., 2018). This heterogenous disorder typically develops in infancy or at latest in the first 
three years of existence and includes Asperger’s syndrome, Kanner’s syndrome, childhood 
disintegrative disorder, nonspecific pervasive developmental disorder and Rett’s syndrome  (Lord et al., 
2000, Hrabovska and Salyha, 2016).  
There are several risk factors which can result in ASD’s developing like genetics, as mutations, 
interaction of certain genes and inheritance has been reported as risks (Frith and Happé, 2005, Faras et 
al., 2010, Hrabovska and Salyha, 2016). There are also environmental risk factors for autism which 
include medical procedures, stress, environmental chemicals and drugs (Dietert et al., 2011). Drugs like 
thalidomide and valproic acid (VPA) have become easier to access, which correlates with the increased 
prevalence of autism (Dietert et al., 2011). 
Valproic acid is used in creating an autism model as it can result in epigenetic modifications (Gadad et 
al., 2013, Mabunga et al., 2015). VPA is clinically a medication for mood swings as well as epilepsy, 
however usage of this acid during childbearing years and early pregnancy has raised much concern 
because for many years, it was associated with several teratogenic effects and as of recent, increased 
risk for autism (Mabunga et al., 2015). However, autism studies have not fully established how altered 
neurotransmitter pathways result in autistic-like behaviour as a result of VPA exposure.  
The primary aim of this study is to investigate how VPA alters the major neurotransmitter system 
pathways, which result in autistic-like behaviour. 
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MATERIALS AND METHODS 
Mating 
Rats were obtained from the Biomedical Resource Unit of the University of Kwa-Zulu Natal and were 
kept in a humidity-and-temperature-controlled facility with a 12-hour light/dark cycle with water and 
food ad libitum. All the procedures performed were in accordance with the Animal Research Ethics 
Committee (AREC) regulations for animal experimentation, in South Africa (AREC/044/018M). 4 adult 
female rats were placed together for 5 days to synchronise their oestrous cycle. For mating, a ratio of 2 
females: 1 male was used. Positive mating was indicated through the presence of sperm in the vaginal 
smears. The initial positive mating represented the gestational day 0 of the study (GND 0). 
Valproic acid model 
On gestational day 12.5 (GND 12.5), the pregnant mothers in the experimental group were injected 
intraperitoneally with a once off 500 mg/kg valproic acid (Sigma-Aldrich, SA) injection in 0.9% saline 
(100 mg/ml, pH 7.3), whilst the control group were injected with a once off saline injection (0.9%, 3.3 
ml/kg). Rats were housed 2 per cage until birth. 
Study Subjects 
A total of 24 male and female Sprague-Dawley rat pups were obtained from the pregnant dams and used 
as test subjects in this study. The pups remained undisturbed, with the exception of routine cleaning of 
the cages once a week, with their mothers in clean cages that contained bedding, water and food. The 
pups were weaned on PND 21.  
Behavioural Assessment 
The Novel-object Recognition Test was performed on PND’s 22-25 to assess the animal’s behaviour 
when exposed to familiar and novel objects, to examine for memory alterations. Whilst the Open Field 
Test was performed on PND 26 to test for repetitive behaviour, explorative and motor function 
Open field test 
The open field test was used to assess the pup’s explorative behaviour and motor function (Walsh and 
Cummins, 1976). Each rat was placed inside a 1m x 1m plexi-glass box, with 50 cm high sides. The box 
was demarcated with tape into 25 squares of equal size. The rat was placed in the centre square and 
allowed to move freely for 5-minutes, during which the time in the centre of the square, total number of 
lines crossed, rears on hind limbs, number of times of urination and defaecation was recorded. The box 
was cleaned with 70% ethanol after each rat. 
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Novel-object recognition test 
The novel-object recognition test was used to assess the pup’s response to a novel object in a 33x55x19.5 
cm cage with a floor area of 1815². This test consisted of three phases namely, the habituation, 
familiarization, and test phase (Antunes and Biala, 2012).  
The habituation phase: was conducted prior to the test on PND’s 22 and 23 for 5-minutes per day in the 
testing apparatus whereby the pups freely explored the open-field area which lacked objects. The pups 
were then subjected to a 1-minute retention interval. 
The familiarization phase: was thereafter conducted, on the same PND’s as mentioned above, whereby 
a single pup was then placed for 10-minutes into the open-field area which contained 2 identical objects. 
The test phase: on PND 24 comprised of an acquisition phase and a test phase, with a 1-hour break in 
between. In the acquisition phase, the pups were left for 5-minutes to explore the familiar objects that 
were placed near the 2 corners in the testing apparatus. 1-hour later, the animal was placed back into the 
testing apparatus, and presented with objects in the same positions as at acquisition, however 1 object 
was familiar whilst the other was a novel object. The pups were left to explore the objects for 10-minutes 
and the Discrimination Index (DI), which allows for the differentiation between the time spent exploring 
the familiar (TF) vs novel (TN) objects, was calculated using the following calculation [DI= (time spent 
with novel object -time spent with familiar object)/(time with novel object + time with familiar object)] 
(Antunes and Biala, 2012). This result can vary between +1 and −1, whereby a negative score indicates 
more time spent with the familiar object, a positive score indicates more time spent with the novel object, 
and a zero score indicates a null preference (Antunes and Biala, 2012). 
Sacrifice and tissue collection  
On PND 27 all the pups were euthanised by decapitation. Brain tissue was removed and placed in frozen 
saline in order to stop all biological processes including loss of proteins. This brain tissue was then 
dissected, to acquire and remove the hippocampus, cerebellum and prefrontal cortex. 
Neurochemical analysis 
Glutamate Assay  
Glutamate levels were measured in the prefrontal cortex and hippocampi tissue samples using a 
Glutamate Assay Kit (ab83389) (Abcam Biotechnology, UK). Samples (20mg) were homogenized in 
assay buffer (200l) through sonication and incubated on ice for 15 minutes and then centrifuged for 2 
minutes at 4C (15 000 rpm). The samples, standards and background control samples (50l each) were 
pipetted into the respective wells in a 96 well plate. The Reaction mix (100l) was then added in to each 
of the standard and sample wells whilst the Background Reaction mix (100l) was added to each of the 
Background sample wells. This was then followed by mixing the wells and an incubation period of 30 
24 
 
minutes at 37C. The Optical Density was then measured immediately using a micro-plate reader 
(SPECTROstar Nano, BMG Labtech, USA) set at 450nm. 
Real Time Polymerase chain reaction (RT PCR) 
RT PCR was conducted to assess the expression of Gamma-aminobutyric acid B Receptor 1 (GABBR1) 
and Gamma-aminobutyric acid type A receptor subunit beta-3 (GABRB3) in the hippocampus and 
cerebellum. All the primers were obtained from Inqaba Biotechnical Industries.  
RNA Extraction 
RNA was extracted from the tissue samples using of an RNA extraction kit (Zymo Research, United 
States). Samples were sonicated in RNA lysis buffer (500l) then centrifuged at 12 000 rpm then the 
lysate was transferred to a Zymo-spin column and centrifuged at 8000 rpm for 30 seconds. Ethanol was 
added followed by centrifuging at 12 000 rpm for 1 minute. Thereafter, RNA prep buffer (400l) was 
added and centrifuged for 1 minute at 12 000 rpm. Column was washed twice, first with 800l and then 
with 400l wash buffer. DNase/RNase free water (50l) was added. The tube was centrifuged at 10 000 
rpm for 30 seconds and RNA concentration and purity were determined by the Nanodrop.  
CDNA synthesis 
CDNA synthesis was performed using the iScript CDNA synthesis kit (Bio-Rad, South Africa). A 
reaction mix of 20l was made following the manufacturers guidelines in the protocol. Thereafter, the 
complete reaction mix was put in to a thermal cycler with these conditions: priming (25C for 5 minutes), 
reverse transcription (20 minutes at 46C), RT inactivation for 1 minute (96C) and hold (4C). 
RT PCR    
The primers were made in to a stock solution according to Inqaba Biotechnical Industries and then 
further diluted to make working solutions. Each of the PCR tubes contained the following: 3l nuclease 
free water, 10l SYBR Green, 1l reverse primer, 1l forward primer and 5l CDNA sample. GAPDH 
was used as the housekeeping gene. The Lightcyler 96 was programmed for denaturation (94C, 5 mins), 
annealing (GABBR1-60C), (GABRB3-56C), (GAPDH-62C) for 45 seconds and extension (72C, 8 
mins), for 45 cycles. PCR tubes were loaded and run. Data analysis was performed by: gene 
concentration/GAPDH concentration=final concentration 
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Table 1: The Forward and Reverse primer sequences for GABBR1 and GABRB3 
Statistical analysis 
Graph Pad Prism Version 7 was used for statistical analysis. For all the tests performed, groups were 
compared using an Unpaired t test. P values of <0.05 were considered significant. All data sets are shown 
as the mean ±SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Receptor Forward Primer Sequence Reverse Primer Sequence 
GABBR1 CAGCAAGTGTGACCCAGGGCAA ATCCGGGCAGCCTCAGCTACAA 
GABRB3 ATCGAGCTCCCACAGTTCTC TCAATGAGAGTCGAGGGTAGG 
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RESULTS 
The Open Field Test  
The open field test was performed in the control and VPA groups to assess rearing and ambulation. 
 
Rearing in the Open Field Test: 
The VPA group had a significant increase in the number of rearing’s when compared to the control NS 
group *(Control vs VPA; p<0,0001, Fig 1) which indicates a VPA effect.  
 
 
 
Figure 1: The frequency of rearing in the control and VPA group during the Open field test (n=12). 
*(Control vs VPA; p<0,0001) 
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Ambulation in the Open Field Test: 
The VPA group significantly ambulated more when compared to the control group *(Control vs VPA; 
p<0,0001, Fig 2) which indicates a VPA effect.  
 
 
 
Figure 2: The number of lines crossed by the animals in the control and VPA group during the Open 
field test (n=12). *(Control vs VPA; p<0,0001) 
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The Novel Object Recognition Test  
The novel object recognition test was performed in the control and VPA groups to determine the 
discrimination index.  
 
Discrimination index from the Novel Object Recognition Test: 
The VPA group had a significantly lower discrimination index when compared to the control group 
*(Control vs VPA; p = 0,0431, Fig 3) which indicates a VPA effect.   
 
 
 
Figure 3: The Discrimination indexes obtained for the control and VPA group during the novel object 
recognition test (n=12). *(Control vs VPA; p = 0,0431) 
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Glutamate concentration 
A Glutamate assay was conducted to determine the glutamate concentration in the control and VPA 
groups. 
 
The Glutamate concentration in the prefrontal cortex and hippocampus: 
The VPA group exhibited significantly lower glutamate concentrations in their prefrontal 
cortices*(control vs VPA; p= 0,0095, Fig 4A) and hippocampi *(control vs VPA; p= 0,0036, Fig 4B) 
when compared to the control group which indicates a VPA effect.  
 
 
 
Figure 4: The concentration (ng/mL) of glutamate in the prefrontal cortex (A) and hippocampus (B) 
observed in the control and VPA group (n=3). 4(A) (control vs VPA; p=0,0095) 4(B) *(control vs VPA; 
p= 0,0036) 
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GABA Receptors 
RT PCR was conducted to determine the of Gamma-aminobutyric acid B Receptor 1 (GABBR1) and 
Gamma-aminobutyric acid type A receptor subunit beta-3 (GABRB3) concentrations in the control and 
VPA groups. 
 
The GABA B Receptor 1 concentration in the hippocampus and cerebellum: 
There were no differences in the hippocampi and cerebellums of the VPA and control groups (p>0,05). 
 
 
 
Figure 5: The concentration (ng/mL) of GABBR1 in the hippocampus (A) and cerebellum (B) of the 
control and VPA group (n=6). 
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The GABA type A receptor subunit beta-3 concentration in the hippocampus and cerebellum: 
The VPA group exhibited significantly higher GABRB3 concentrations in their hippocampi when 
compared to the control group *(control vs VPA; p =0,0029, Fig 6A) which indicates a VPA effect. 
 
There were no differences in the GABRB3 concentration in the cerebellums of the control and VPA 
groups (p>0,05) indicating that there was no VPA effect. 
 
 
 
Figure 6: The concentration (ng/mL) of GABRB3 in the hippocampus(A) and cerebellum (B) of the 
control and VPA group (n=4/6). 6(A) *(control vs VPA; p =0,0029) 
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DISCUSSION 
The current study investigated the mechanism of action used by VPA to cause an autistic-like phenotype 
in a rat model by assessing the behaviour, glutamatergic and GABAergic systems. 
 
The open field test was conducted to assess rearing and ambulation. Our results show an increase in 
rearing following exposure to VPA. Several studies have documented rearing to be a repetitive 
behaviour (Ryan et al., 2010, Kim et al., 2016, Hisaoka et al., 2018). This result is similar to Hisaoka et 
al. (2018), who also found an increase in rearing. Repetitive behaviour is one of the core symptoms of 
ASD and different models have been used to assess this phenomenon (Ryan et al., 2010, Kim et al., 
2016, Hisaoka et al., 2018). ASD models have observed ambulation as a sign of locomotive function, 
exploration and even as being a form of emotional behaviour but there is inadequate proof (Archer, 
1973, Tatem et al., 2014). Our results show an increase in ambulation following VPA exposure. This is 
a result of  hyperactivity in a new environment,  which has been previously documented by Narita et al. 
(2010) and also observed in human autism. 
 
We further conducted the novel object recognition test to determine the discrimination index as a 
measure of memory. Our study documented positive discrimination indexes for the control group in 
contrast to the VPA group. This indicated that the control pups spent more time with the novel object 
whilst the VPA pups spent more time with the familiar object. According to Lueptow (2017) if novel 
object recognition memory is intact then the animals will remember the familiar object and will therefore 
spend more time with the novel object. Hence this suggests that the memory of the control group was 
intact, whilst the VPA animal’s memory was impaired (Antunes and Biala, 2012, Lueptow, 2017). Hou 
et al. (2018) and Banerjee et al. (2014) documented that rats exposed to VPA also exhibited memory 
impairments. This result is imperative since past studies have documented that prenatal exposure to 
VPA results in the offspring’s exhibiting autistic behaviour and autistic individuals have been associated 
with episodic memory deficits which includes explicit retrieval of past experiences (Cooper et al., 2017, 
Fujimura et al., 2017). 
 
To further confirm the behaviour observed in this study we assessed the glutamate neurotransmitter 
system as repetitive behaviour is due to an imbalance of the excitatory/inhibitory signalling in the 
developmental period (Mehta et al., 2011). This study observed abnormally decreased glutamate levels 
in the hippocampi of the VPA exposed animals which is in agreement with numerous past studies 
(Carlsson, 1998, Purcell et al., 2001, Jamain et al., 2002, Cetin et al., 2015). Disrupted signalling of 
glutamate is imperative in repetitive behaviour as hypo-glutamatergic animal models have been 
documented to exhibit autistic characteristics including restricted behaviour with the inability to change 
behaviour and deficient habituation (Jamain et al., 2002, Koppers, 2010). Evidence suggests that 
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glutamate experiences disrupted signalling in autism, especially the signalling of  its metabotropic 
glutamate receptors, which plays a part in dendritic translation (Mehta et al., 2011, Peralta et al., 2016). 
In addition, the amygdaloid-hippocampal pathway is overly activated in ASD models (Kim et al., 2016). 
VPA has been documented to cause mGluR1a (metabotropic glutamate receptor type 1) over-
functioning in the hippocampus which alters definite regulatory pathways that affect the processing of 
the hippocampus which may be the cause of autistic behaviour (Peralta et al., 2016). This study observed 
memory deficits in the VPA rats which are also seen in autistic individuals whom are associated with 
episodic memory deficits (Cooper et al., 2017, Fujimura et al., 2017). The glutamate concentration was 
used to confirm this change as glutamate is essential for cognitive functions like learning and memory 
(Carlsson, 1998, Jamain et al., 2002, Koppers, 2010, Cetin et al., 2015, Horder et al., 2018). Our study 
observed that the VPA exposed rats had decreased glutamate in the PFC. This finding was also 
documented by several other studies (Carlsson, 1998, Jamain et al., 2002, Koppers, 2010, Cetin et al., 
2015, Horder et al., 2018). This alteration in the glutamate neurotransmitter system suggests that there 
are alterations in the glutamate receptors (Jamain et al., 2002, Tarabeux et al., 2011, Uzunova et al., 
2014). Uzunova et al. (2014) documented alterations of the NMDAR in the PFC which is essential for 
cognitive processes and these alterations could possibly result in memory deficits. Whilst Jamain et al. 
(2002) documented that a dysfunction of the glutamate receptor 6 (GluR6), which is a member of the 
ionotropic kainate receptors, plays a role in learning impairments of autistic subjects. Furthermore, 
mutations of this receptor could pose consequences on the integration of excitatory synaptic signals 
which control these behavioural aspects and alterations in the editing process of GluR6 mRNA, can also 
play a role in the autistic phenotype (Jamain et al., 2002).   Our results suggest that autism is a Hypo-
glutamatergic condition which is in agreement with numerous past studies (Carlsson, 1998, Purcell et 
al., 2001, Jamain et al., 2002, Cetin et al., 2015).                
                                                                                                                                            
This study observed hyperactivity in VPA-rats which is also seen in human autism and is linked to 
cerebellar abnormalities (Pierce and Courchesne, 2001, Narita et al., 2010). We further confirmed this 
behavioural change by assessing the GABAergic neurotransmitter system as numerous studies have 
shown that disruption in this pathway is associated with the autism pathogenesis (Chen et al., 2014). 
The current study found that the rats exposed to VPA showed no difference, however a decreasing trend 
in the GABBR1 concentration was seen in the cerebellum. Autism presents abnormal cerebellar 
development and these abnormalities are considered to be responsible for the dysfunction of the motor 
system commonly observed (Nayate et al., 2005, Fatemi et al., 2009b, Rogers et al., 2013). The motor 
deficits seen in autism is linked to cerebellar irregularities like Purkinje cell loss (Fatemi et al., 2012, 
Rogers et al., 2013). In addition, Fatemi et al. (2009a) found significantly decreased levels of GABBR1 
in the cerebellums of individuals with autism. The current study however, did not document a significant 
difference which could possibly be due to using rat brain tissue as compared to human brain tissue used 
by Fatemi et al. (2009a) or because our autistic rats did not comorbidly experience seizures, which cause 
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a long-term decrease in GABBR1 (Han et al., 2006). Another candidate gene for autism is GABRB3, 
which is essential during development for mediating excitatory signalling, differentiation and neuronal 
growth (Warrier et al., 2013, Chen et al., 2014). Our study found that the VPA exposed rats showed no 
difference, however an increasing trend for the GABRB3 concentration was observed in the cerebellum. 
We found that the VPA exposed rats had an increase in GABRB3 and showed no difference, but an 
increasing trend for the GABBR1 concentration in the hippocampus. Dickerson et al. (2011) found a 
significant increase of GABAB receptor 1 whilst, in 2014 (Chen et al.) found that increased expression 
of GABRB3 contributes to the pathogenesis of autism. Chen et al. (2014) suggested that missense 
mutations and rare variants in the 5′ regulatory region of GABRB3 is associated with autism which 
implies altered gene expression of GABRB3 is involved in autism’s neurobiology. Such mutations can 
influence the structure of the secondary protein and change a phosphorylation-based binding motif or 
phosphorylation-based substrate motif which could have a functional effect on GABRB3 (Chen et al., 
2014). Furthermore, the dysfunction in the neurons of the GABAergic system has been suggested to 
cause a sensitization and/or upregulation of the postsynaptic GABAA receptors, which is possibly the 
reason for increased expression of GABRB3 (Rudolph and Möhler, 2014). Gaetz et al. (2014) found 
that individuals with autism exhibited decreased levels of GABA in the motor cortex and this could 
possibly be the reason for the upregulation of GABRB3. In addition, Rudolph and Möhler (2014) 
documented that an upregulation of α5 GABAA receptors impaired cognitive performance, which is 
significant in the current study where we see an upregulation of GABA receptors and impaired cognitive 
function. Impaired memory may be a result of disruptions in the firing activity of the cortical networks 
which is usually arranged by the parvalbumin interneurons, the latter of which is insufficient in GABA 
release due to reduction in GAD67 expression (Charych et al., 2009). Mice lacking GABRB3 and 
GABBR1 have been documented to exhibit several behavioural abnormalities including deficits in 
memory and learning therefore, alterations in the expression of these receptors may lead to these 
memory and learning deficits (Fatemi et al., 2009a, Chen et al., 2014). In addition, mutations of these 
receptors may be associated with autism and even their expression may be affected by epigenetic 
alterations (Fatemi et al., 2009a, Chen et al., 2014). Our study however, did not document a significant 
difference for the GABRB3 concentration in the cerebellum which could be due to the fact that Chen et 
al. (2014) used human patients from Taiwan and genomic DNA was prepared from the peripheral blood. 
CONCLUSION 
This study observed that exposure to VPA results in alterations in the functioning of the GABAergic 
and glutamatergic systems which result in the autistic-like phenotype. This was evident as exposure to 
VPA resulted in decreased glutamate in the hippocampus and PFC. VPA exposure also resulted in 
increased GABRB3 in the cerebellum and hippocampus as well as in GABBR1 of the hippocampus 
whilst it caused a decrease in GABBR1 of the cerebellum. These alterations resulted in repetitive 
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behaviour, hyperactivity and impaired memory. Our results show that valproic acid exposure alters the 
glutamatergic and GABAergic systems which results in the autistic-like phenotype.  
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CHAPTER THREE 
 
 
 
Manuscript 2 
 
 
The manuscript consists of a brief introduction, a detailed materials and methods section followed by 
the results and discussion sections. Previously, we have established that valproic acid results in the 
autistic-like phenotype. This manuscript focuses on the effects of maternal separation stress with 
prenatal exposure to VPA. 
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Abstract 
Introduction: There are numerous risk factors for autism, including the exposure to stress. The HPA 
axis, which is the primary stress system, is activated in the event of stress. However prolonged stress 
and early traumatic life events can result in the dysregulation of the HPA axis. Maternal separation is 
an example of prolonged stress in the first two weeks of life. Stress has also been found to exacerbate 
autism symptoms. The valproic acid animal model is used globally to induce autism. This study was 
conducted to determine the effects of maternal separation stress with VPA.  
 
Methods: This study used forty-eight rat pups which were divided in to control (saline-0.9%, 3.3 ml/kg), 
control stressed, VPA (VPA-500 mg/kg) and VPA stressed groups. The stressed groups were subjected 
to maternal separation stress from postnatal day 2-14 for 3-hours (9h00 to 12h00) each day. The open 
field test was conducted to assess the pup’s behaviour. Corticosterone and Serotonin Transporter 
ELISA’s were conducted to measure their concentrations. 
 
Results: Stress exposure with VPA caused a dysregulation in the HPA axis resulting in a sensitized 
stress response. Exposure to stress and VPA also resulted in decreased Serotonin transporter 
concentrations in the amygdala and prefrontal cortex. These alterations were accompanied by anxiety-
like behaviours, namely a decrease in the time spent in the centre and total excretion.  
 
Conclusion: This study showed that valproic acid together with maternal separation stress causes 
dysregulation in the HPA axis and altered serotonergic signalling. 
 
Key Words: Autism, Valproic acid, Maternal Separation Stress, Corticosterone, Serotonin 
                   Transporter  
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Introduction 
Stress can occur in different forms (Dietert et al., 2011). The hypothalamic-pituitary-adrenocortical 
(HPA) axis regulates stress by stimulating the release of glucocorticoids known as cortisol or 
corticosterone (Corbett and Simon, 2014). These glucocorticoids are essential for re-establishing 
homeostatic conditions (Aguilera, 2011, Stephens and Wand, 2012). During the first 14 days of life, the 
stress system is developed and there are low glucocorticoid levels hence being termed the stress-
hyporesponsive period (Lai and Huang, 2011, Schmidt, 2019). If stress is experienced in the early years 
of life or over a prolonged period of time it can result in the dysregulation of the HPA axis causing 
sensitized stress response, adrenal exhaustion and can further lead to alterations in brain functions and 
neurobehavior  (Thomas and Lena, 2010, Herman et al., 2011, Lai and Huang, 2011). Chronic stressors 
can change the responsiveness of the HPA axis, causing it to shift from being over-responsive to non-
responsive (Thomas and Lena, 2010). Prolonged exposure to stress hormones can also predispose 
psychological, metabolic or immune alterations (Aguilera, 2011). The environment to which an 
individual is exposed to during their first years of life has a powerful influence on the development of 
their behavioural responses in adulthood (Weiss et al., 2011).  Maternal separation is an example of 
prolonged early life stress, which  disturbs the mother infant bond during the stress-hyporesponsive 
period to model postnatal stress (Weiss et al., 2011, Nishi et al., 2013). Stress and trauma are not only 
a risk factors for autism, but have been documented to exacerbate autistic symptoms  (Fuld, 2018). 
Autism is a pervasive developmental disorder which is characterized by impaired social reciprocity, 
deficits in communication and by abnormal repetitive, restricted behaviours and interests (Lord et al., 
2000, Frith and Happé, 2005, Faras et al., 2010). A dysfunction in the major neurotransmitter systems 
like the GABAergic, glutamatergic and serotonergic are linked to autism pathogenesis (Trottier et al., 
1999). Serotonin is particularly important in autism as it plays a role in the development of social skills 
and alterations in serotonin during early life can cause irregularities in its metabolism (Brummelte et al., 
2017, Cetin et al., 2015). There is no general agreement with regard to the risk factors or what causes 
autism (Hrabovska and Salyha, 2016). However, exposure to certain environmental conditions like 
stress, chemicals or drugs are risk factors for autism (Dietert et al., 2011). Valproic acid (VPA) is an 
anticonvulsant drug, however usage of this drug by pregnant women is associated with the increased 
risk of autism (Gottfried et al., 2013, Mabunga et al., 2015, Ornoy et al., 2019). VPA is used therefore 
used to create autism animal models, as it can result in epigenetic modifications (Gadad et al., 2013, 
Mabunga et al., 2015). In rats, embryonic exposure to VPA, approximately at the time of closure of the 
neural tube, results in autistic-like behaviour and anatomical abnormalities in the progeny (Favre et al., 
2013). In addition, VPA alters the GABAergic and glutamatergic neurotransmitter systems which are 
linked to the core symptoms experienced in autism (Carlsson, 1998, Jamain et al., 2002, Koppers, 2010, 
Cetin et al., 2015, Horder et al., 2018).  
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This study aims to determine the effects of maternal separation stress together with prenatal exposure to 
VPA. 
Materials and Methods 
Mating 
Rats were obtained from the Biomedical Resource Unit of the University of Kwa-Zulu Natal and were 
kept in a humidity-and-temperature-controlled facility with a 12-hour light/dark cycle with water and 
food ad libitum. All the procedures that were performed were in accordance with the Animal Research 
Ethics Committee (AREC) regulations for animal experimentation, in South Africa (AREC/044/018M). 
Eight adult female rats were placed together for 5 days to synchronise their oestrous cycle, which is 
described as the “special period of sexual desire of the female” by Westwood (2008). For mating, a ratio 
of 2 females: 1 male was used. Positive mating was indicated through the presence of sperm in the 
vaginal smears. The initial positive mating represented the gestational day zero of the study (GND 0). 
Valproic acid model 
On gestational day 12.5 (GND 12.5), the pregnant dams in the experimental group were injected 
intraperitoneally with a once off 500 mg/kg valproic acid (Sigma-Aldrich, SA) injection in 0.9% saline 
(100 mg/ml, pH 7.3), whilst the pregnant dams in the control group were injected with a once off saline 
injection (0.9%, 3.3 ml/kg). Rats were housed/kept 2 per cage until birth. 
Study Subjects 
A total of 48 male and female Sprague-Dawley rat pups were obtained from the pregnant dams and used 
as test subjects in the following study. The control and VPA non-stressed pups remained undisturbed, 
with the exception of routine cleaning of the cages once a week, with their mothers in clean cages that 
contained bedding, water and food. Whilst the control and VPA stressed pups were separated from their 
mothers to conduct the maternal separation stress protocol. All pups were weaned on PND 21.  
Maternal separation stress protocol 
The rat pups were separated in to groups, shown in table 1, according to the injections their mothers 
were given, namely VPA and control (saline). These groups were then further split in-to groups that 
were stressed and groups that were not exposed to stress.  
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CONTROL GROUP VPA GROUP 
Control Non-
stressed 
Control 
Stressed 
VPA Non-
stressed 
VPA Stressed 
Mother had 
saline 
injection 
Mother had 
saline 
injection 
Mother had 
VPA injection 
Mother had 
VPA injection 
No Stress Stressed No stress Stressed 
 
Table 1: How the different groups were split based on injections and stress exposure 
 
2 days after birth, the rat pups that were to be stressed in the experimental and control groups were 
subjected to stress through maternal separation from postnatal day (PND) 2-14. These pups were 
stressed by using the 3-hour model (9h00 to 12h00). This essentially means that the dams were placed 
in to clean cages, whilst the pups remained in the home cage alone for 3-hours for each day. Dams and 
litters were situated in such a way that there was no olfactory and visual contact. After the 3-hour interval 
the dams were returned to their home cage with the pups.  
Assessment of pups  
The Open Field Test was performed on PND 26 to the pup’s anxiety and stress. 
Open field test 
The open field test was used to assess the pup’s stress and anxiety (Kristina et al., 2017). Each rat was 
placed inside a 1m x 1m plexi-glass box, with 50cm high sides. The box was demarcated with tape into 
25 squares of equal size. The rat was placed in the centre square and allowed to move freely for five 
minutes, during which the time in the centre of the square, total number of lines crossed, rears on hind 
limbs, number of times of urination and defaecation was recorded. The box was cleaned with 70% 
ethanol after each rat. 
Sacrifice and tissue collection  
On PND 27 all the pups were euthanised by decapitation. Blood was collected in EDTA coated 
collecting tubes using a funnel. Once the blood was in the collecting tubes, it was then shaken and stored 
in a Bio freezer until it was required for neurochemical analysis. Brain tissue was removed and placed 
in frozen saline in order to stop all biological processes including loss of proteins. This brain tissue was 
then dissected, to acquire and remove the amygdala and prefrontal cortex for further analysis.  
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Neurochemical analysis 
The following study used a corticosterone enzyme-linked immunosorbent assay (ELISA) kit and 
Serotonin Transporter ELISA kit to determine the concentration of corticosterone and serotonin 
transporter respectively. 
Corticosterone ELISA 
The Corticosterone (CORT) levels were measured in plasma samples using an ELISA kit (Elabscience 
Biotechnology, USA) which used the competitive ELISA principle. The samples and standards (50l 
each) were pipetted into the respective wells on the precoated ELISA plate. Detection Ab (50l) was 
immediately added to each well, followed by incubation for 45-minutes at 37C. After incubation, the 
wells were then washed 3 times using a Wash Buffer (350l per wash) and thereafter Enzyme Conjugate 
was added to each well (100l). This was followed by an incubation period of 30-minutes at 37C. The 
wash step was repeated and the Substrate Solution was added (90l). After a 15-minute incubation 
period the Stop Solution (50l) was added to each well and the Optical Density was measured 
immediately utilizing a micro-plate reader set at 450nm. 
Serotonin Transporter ELISA 
The Serotonin Transporter levels were measured in the amygdala and prefrontal cortex using a Rat 
Serotonin Transporter (SERT) ELISA kit (Elabscience Biotechnology, USA) which used the Sandwich-
ELISA principle. The tissue was homogenized in PBS (tissue weight (mg): PBS (l), 1:9) through 
sonication. The samples and standards (100l each) were pipetted into the respective wells on the 
precoated ELISA plate and was then incubated for 90-minutes (37C). Liquid was removed without 
washing and Detection Ab (100l) was then added to each well, followed by incubation for 60-minutes 
(37C). Wells were then washed 3 times using Wash Buffer (350l per wash) and thereafter Enzyme 
Conjugate was added (100l). This was then incubated for 30-minutes (37C). Wells were washed again 
and Substrate Solution was added (90 l). Following a 15-minutes incubation period at 37C, Stop 
Solution (50l) was added to each well and the Optical Density was measured immediately using a 
micro-plate reader set at 450nm. 
Statistical analysis 
Graph Pad Prism Version 7 was used for statistical analysis. For all the tests performed, groups were 
compared using a Two-way ANOVA. The Turkey’s post-hoc test was then performed to determine 
significance between groups. P values of <0.05 was considered significant. All data sets are shown as 
the mean ±SEM. 
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Results 
The Open Field Test  
The open field test was performed in the control non-stressed (NS), control stressed (S), VPA non-
stressed (VPA NS) and VPA stressed (VPA S) groups to assess the time spent in the centre and total 
excretion. 
 
The time spent in centre during the Open field test: 
 The VPA S group spent significantly less time in the centre when compared to the VPA NS group 
*(VPA NS vs VPA S; p=0,0002; F (1, 44) = 32,21, Fig 1) which indicates a stress factor. Furthermore, 
The VPA S group also spent less time in the centre when compared to the control NS group, however 
this result is not statistically significant (p>0,05). There were no differences between the NS groups 
(p>0,05). 
 
 
 
Figure 1: The time spent in the centre by the respective groups (control NS, control S, VPA NS and 
VPA S) during the Open field Test. All data are expressed as mean ±SEM, (n=12). *(VPA NS vs VPA 
S; p=0,0002) 
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The Total excretory waste during the Open field test: 
The VPA S group had a significant reduction in waste when compared to the VPA NS group *(VPA NS 
vs VPA S; p=0,0044; F (1, 44) = 13,85, Fig 2) which indicates a stress effect. The VPA S group also 
excreted less waste when compared to the control NS group, whilst the VPA NS group excreted more 
waste when compared to the control NS group however these results are not statistically significant 
(p>0,05).   
 
 
 
Figure 2: The total excretory matter of animals in the respective groups (control NS, control S, VPA NS 
and VPA S) during the Open field test. All data are expressed as mean ±SEM, (n=12). *(VPA NS vs 
VPA S; p=0,0044) 
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Corticosterone concentration 
The Corticosterone concentration observed in the blood: 
A corticosterone ELISA was conducted to determine the corticosterone concentration in the control non-
stressed (NS), control stressed (S), VPA non-stressed (VPA NS) and VPA stressed (VPA S) groups.  
 
The VPA NS group also exhibited a significantly higher corticosterone concentration when compared 
to the control NS group **(Control NS vs VPA NS; p=0,0025; F (1, 8) = 17,8, Fig 3) which indicates a 
VPA effect. 
 
The control S group exhibited a significantly higher corticosterone concentration compared to the 
control NS group *(Control NS vs Control S; p=0,0337; F (1, 8) = 1,822, Fig 3) whilst the VPA S group 
exhibited a significantly lower corticosterone concentration when  compared to the VPA NS group 
****(VPA NS vs VPA S; p<0,0001; F (1, 8) = 1,822, Fig 3), which indicates a stress effect.  
 
Furthermore, the VPA S group exhibited a significantly lower corticosterone concentration compared 
to the control S group ****(Control S vs VPA S; p=0,0003; F (1, 8) = 83,64, Fig 3) which indicates an 
overall effect from both stress and VPA.   
 
 
 
Figure 3: The concentration (ng/ML) of corticosterone observed in the blood from animals of the 
respective groups (control NS, control S, VPA NS and VPA S). All data are expressed as mean ±SEM, 
(n=3). *(Control NS vs Control S; p=0,0337), ****(VPA NS vs VPA S; p<0,0001), **(Control NS vs 
VPA NS; p=0,0025), ****(Control S vs VPA S; p=0,0003) 
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Serotonin transporter concentration 
The Serotonin transporter concentration in the amygdala and prefrontal cortex: 
A serotonin transporter ELISA was conducted to determine the SERT concentration in the control non-
stressed (NS), control stressed (S), VPA non-stressed (VPA NS) and VPA stressed (VPA S) groups.  
 
The control S group exhibited significantly higher concentrations of SERT in their amygdalae compared 
to the control NS group *(control NS vs control S; p = 0,0195; F (1, 8) = 1,115, Fig 4A) which indicates 
a stress effect.  
 
Whilst the VPA S group exhibited significantly lower concentrations of SERT in their amygdalae when 
compared to the control S group **(control S vs VPA S; p = 0,0013; F (1, 8) = 19,68, Fig 4A) which 
indicates an overall effect from both stress and VPA.  
 
The VPA S group exhibited the lowest levels of SERT in their PFC’s when compared to all the other 
groups, however these differences observed are not statistically significant (p>0,05) which indicates that 
there was neither a stress or prenatal exposure to VPA effect. 
 
 
Figure 4: The concentration (ng/mL) of SERT observed in the amygdala (A) and prefrontal cortex (B) 
of the respective groups (control NS, control S, VPA NS and VPA S). All data are expressed as mean 
±SEM, (n=3). 4(A) *(control NS vs control S; p = 0,0195), **(control S vs VPA S; p = 0,0013) 
 
 
 
 
50 
 
Discussion  
The current study investigated how maternal separation stress affected rats that were prenatally exposed 
to VPA by assessing behaviour, corticosterone and the serotonergic system. 
 
The open field test is one of the most commonly used tests in behavioural research which examines 
anxiety-related responses and emotionality in rats (Sestakova et al., 2013). The current study observed 
that the VPA stressed group spent less time in the centre when compared to the VPA non-stressed group. 
This is an important finding since Sestakova et al. (2013) interpreted less time spent in the centre and 
more time spent in the periphery/corners to be a sign of anxiety. In addition, stress and the emerging 
rise in glucocorticoid levels are said to be involved in depressive disorder’s pathophysiology (Chiba et 
al., 2012). Chiba et al. (2012), documented that chronic stress in rats resulted in depressive and anxiety-
like behaviour. These findings mentioned above are in agreement to the current study which observed 
anxiety-like behaviour due to stress. Defaecation and urination is a negatively associated measure of a 
rodent’s emotions and is also a measure of anxiety (Seibenhener and Wooten, 2015). According to 
Tobach (1966) urination and defaecation can be merged together to generate a composite elimination -
score. The current study found that the VPA stressed group excreted less when compared to the VPA 
non-stressed group, which is in agreement to Roth and Katz (1979), who documented that stressed 
animals defaecated less during the open field test. The increase in excretion in the non-stressed group 
could be a result of the animal being fearful/anxious about its exposure to the new and possibly unsafe 
environment, which is further confirmed by the neurochemical analysis (Sestakova et al., 2013).  
 
Stress leads to the activation of the  hypothalamic–pituitary–adrenal (HPA) axis which is responsible 
for regulating the glucocorticoid levels and the main circulating glucocorticoid in rodents is 
corticosterone (Raubenheimer et al., 2006, Mishima et al., 2015). Corticosterone is the crucial stress 
hormone which is manufactured in the adrenal glands’ cortex and has a regulating responsibility for the 
HPA axis activity in rodents (Mishima et al., 2015). In the event of stress, corticosterone is responsible 
for promoting self-maintenance as well as escape behaviours, increasing certain immune parts and 
makes stored energy readily available (Lattin and Romero, 2014). Therefore, to further confirm the 
stress observed in the pup’s behaviour we assessed the corticosterone concentration where we observed 
a higher corticosterone concentration in the control stressed group when compared to the control non-
stressed group. This result is expected since the exposure to stress activated of HPA axis which resulted 
in the production of corticosterone (Raubenheimer et al., 2006, Mishima et al., 2015). Whilst, the VPA 
non-stressed group exhibited a higher corticosterone concentration than the VPA stressed group. If  
stress is experienced in the early years of life or over a prolonged period of time it can result in the 
dysregulation of the HPA axis causing sensitized stress response as seen in the current study  (Thomas 
and Lena, 2010, Herman et al., 2011, Lai and Huang, 2011). Many studies with chronic stress have 
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documented decreased corticosterone negative feedback and even expression of receptors in the related 
brain areas (Sapolsky et al., 1984, Mizoguchi et al., 2003, Dickens et al., 2009). In addition, Dickens et 
al. (2009) found that exposure to more than one stressor can possibly alter the stress response (HPA 
axis) which can then result in the negative feedback system experiencing decreased sensitivity. 
Essentially the decreased corticosterone concentration exhibited by the stressed VPA group of the 
current study could be as a result of decreased sensitivity of the negative feedback system (Sapolsky et 
al., 1984, Mizoguchi et al., 2003, Dickens et al., 2009). The current study also observed that the control 
non-stressed group exhibited a significantly lower corticosterone concentration when compared to the 
VPA non-stressed group. This is a  result of exposure to VPA which has been documented to cause 
hyperactivity in a new environment (Narita et al., 2010). This increase in locomotive activity has been 
documented to result in correlated differences in the HPA axis which leads to increased corticosterone 
concentrations (Malisch et al., 2006). In addition, the VPA non-stressed group of this study exhibited 
the highest corticosterone concentration which further conveyed these animal’s fear due to exposure to 
the new and a possibly unsafe environment (Sestakova et al., 2013). This increase in corticosterone 
concentration could also be as a result of mild novelty, such as the cleaning of cages, which has been 
shown to increase corticosterone concentrations (Hennessy and Levine, 1977, Malisch et al., 2006). Our 
study also noted a significant increase in the corticosterone concentration in the control stressed group, 
when compared to the VPA stressed group. This finding tells us that not only does chronic stress result 
in decreased corticosterone negative feedback, but exposure to VPA with maternal separation stress 
yields the same result  (Sapolsky et al., 1984, Mizoguchi et al., 2003, Dickens et al., 2009). 
 
Serotonin is one of the most well-known neurotransmitter’s and is responsible for regulating neural 
activity and an assortment of neuropsychological processes (Berger et al., 2009). The 
neuropsychological and behavioural processes regulated by serotonin include fear, mood, memory, 
anger, perception, attention, aggression and any dysregulation of the serotonergic system has been 
linked to the pathogenesis of several neurological and psychiatric disorders (Berger et al., 2009). The 
serotonin transporter (SERT or 5-HTT) is responsible for the accumulation of serotonin in to the cells 
after 5-HT1is  released, therefore regulating the serotonergic neurotransmission plus signalling and was 
therefore assessed to confirm the anxious behaviour seen in this study (Ramsey and De Felice, 2002). 
The amygdala, which is part of the limbic system, has been revealed to play a role in emotional response, 
with proof of its amygdaloid subnuclei playing a role in the regulation of fear, attention, memory and 
sexually-related behaviours in rats (Rasia-Filho et al., 2000). In this study we found that the control non-
stressed rats exhibited a lower SERT concentration when compared to the control stressed group. Oler 
et al. (2009), found that the availability of SERT in the amygdala area has a positive correlation with 
behaviour of anxious temperament. Our findings are in agreement with that of Oler et al. (2009), as we 
see that the anxious behaviour of the control group resulted in more SERT being available in their 
amygdalae. We also observed that the control stressed group exhibited higher amygdala SERT 
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concentrations when compared to the VPA stressed group.  Prenatal exposure to VPA has been shown 
to result in decreased SERT levels (Dufour-Rainfray et al., 2010). In addition, mice and rats lacking 
SERT have been found to present autistic-like features (Homberg et al., 2007, Moy et al., 2009). 
We further confirmed the SERT concentrations in the prefrontal cortex (PFC) which is linked to 
cognitive functions, memory, general intelligence and behavioural inhibition (Siddiqui et al., 2008, 
Wilson et al., 2010). The current study observed that the non-stressed groups had a tendency to exhibit 
higher SERT concentrations in their PFC’s when compared to their respective stressed groups. This is 
in accordance with Murphy and Lesch (2008) who documented that stress will result in decreased 
serotonergic activity and therefore less SERT. The VPA groups of this study also exhibited lower SERT 
concentrations when compared to the control groups, as VPA exposure has been documented to decrease 
SERT levels, as mentioned previously (Dufour-Rainfray et al., 2010). 
Conclusion 
This study observed that the exposure to stress and VPA resulted in anxiety-like behaviour. We found 
that VPA exposure resulted in an increased corticosterone concentration whilst stress with VPA resulted 
in the dysregulation of the HPA axis as we observed decreased corticosterone concentration. We also 
found that when VPA and stress exposure was coupled, it resulted in decreased SERT concentration. 
Our results show that maternal separation stress with VPA causes a sensitized stress response with 
alterations in the serotonergic system. 
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CHAPTER FOUR 
 
 
Chapter four consists of a synthesis which identifies the link between the two studies in this 
dissertation, summarizing the overall findings and states the conclusions from these studies. 
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Synthesis 
Autism is a neurodevelopmental disorder which is becoming more prevalent every day and has therefore 
caused a fear of an epidemic (Frith and Happé, 2005). Autism South Africa has found that 160 autistic 
children are born weekly and 1 child with autism every hour. Autistic individuals display 
communication deficits, repetitive behaviours, impairments in social reciprocation and executive 
function (Lord et al., 2000, Frith and Happé, 2005). However, the display in these impairments vary 
greatly amongst different individuals therefore the autism spectrum was developed (Frith and Happé, 
2005, Faras et al., 2010). VPA is a medication used for epilepsy, however using it during pregnancy has 
caused concern as it is related with the increased risk of autism (Mabunga et al., 2015). There are also 
environmental conditions which make individuals more prone to becoming autistic (Baron-Cohen and 
Bolton, 1993). Disturbances during early development can play a role in causing neurodevelopmental  
disorders (Mpofana et al., 2016). Maternal separation is such a disturbance, as it a form of early life 
stress which can cause changes in the stress response of individuals (Weiss et al., 2011). This study 
intended to find out how VPA changed the functioning of the important neurotransmitter systems, which 
caused autistic-like behaviour. This study also intended to find out what happens to individuals when 
exposed to both VPA and maternal separation stress. Autistic-like symptoms were induced though a 
once of VPA injection in the pregnant mothers. Maternal separation stress was carried out by separating 
the pups from their mothers for 3 hours on postnatal days 2-13. 
 
Following the injection of VPA we recorded number of rearing’s, ambulation and discrimination index 
by carrying out the open field and novel object recognition tests. The concentrations of glutamate and 2 
GABA receptors (Gamma-aminobutyric acid B Receptor 1: GABBR1 / Gamma-aminobutyric acid type 
A receptor subunit beta-3: GABRB3) were measured. We found that VPA causes a decrease in the 
glutamate concentration in the hippocampus which leads to the repetitive behaviour, commonly 
observed in autistic individuals. From this finding we deduced that autism is a hypo-glutamatergic 
condition. We also found that VPA caused a decrease in GABBR1 and an increase in the GABRB3 
concentrations in the cerebellum which resulted in hyperactivity. Lastly, we found that VPA caused a 
decrease in the glutamate concentration in PFC whilst it decreased the GABRB3 and GABBR1 
concentrations in the hippocampus which lead to impaired learning or memory.  
 
We also looked at the effects of maternal separation stress together with VPA exposure. Following 
maternal separation stress and VPA exposure we recorded the time spent in the centre and total excretion 
by carrying out the open field test. The corticosterone and serotonin transporter concentrations were 
measured. We found that stress together with VPA caused a decrease in the time spent in the centre plus 
total excretion, when compared to VPA without stress, which are signs of anxiety and stress. VPA 
exposure lead to an increased corticosterone concentration as it caused hyperactivity thereby increasing 
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movement which in turn caused correlating changes in the stress axis. However, stress with VPA 
exposure lead to a decrease in corticosterone concentration as these factors together caused a dysfunction 
in the stress response, therefore it did not respond normally when stress occurred. Lastly, we found that 
stress together with VPA caused a decrease in the serotonin transporter concentration in the amygdala 
and prefrontal cortex.  
 
This study shows that VPA causes changes in the GABAergic and glutamatergic systems which are 
responsible for causing the autistic-like behaviour seen in autism, however VPA together with maternal 
separation stress causes a dysfunction the stress response plus changes in the serotonergic system. 
Conclusions 
This study showed just how relevant and powerful Valproic acid really is in modern times, as this drug 
is commonly used for treatment globally. However, the consequences of using this drug during 
pregnancy are severe, as shown in this study. Whereby it is evident that prenatal exposure to valproic 
acid results in the autistic-like phenotype. The Valproic acid model is therefore valuable in autism 
research as, it is able to mimic some of the core symptoms of autism allowing us to investigate the 
physiology underlying autistic-like behaviour. This model therefore holds great importance for 
therapeutic measures, as it allows us to uncover the complex pathways affected in autism which can 
then be used in future treatments to address the core symptoms of autism. This study also shows that 
stress is an important factor in autism, as when it is combined with the autistic phenotype it presents 
more severe consequences to the pathways and functioning in the brain. Therefore, it is crucial to 
consider stress in autism therapy because when autistic individuals are exposed to early or prolonged 
stress, this can lead to abnormalities in their stress response, which could result in dire consequences 
and even worsen their autistic symptoms. 
Limitations and Future Recommendations 
Over the years there has been extensive research conducted on autism symptoms, risk factors etc. 
However, there is still a large gap in the knowledge of how this neurodevelopmental disorder causes 
dysfunction in the neurotransmitter systems of the brain. Hence, autism research should prioritise filling 
this gap as this knowledge is imperative for the future treatment of autism. Our study will bring light to 
how detrimental stress is, especially to individuals with autism. Therefore, this study can be used to 
enlighten pregnant mothers, especially those with epilepsy, on the effects that stress may have on their 
children and can therefore be used a preventative measure. As better understanding of autism can 
improve early detection methods and also inform treatment modalities. In addition, this study can then 
inspire future research on autism with stress, especially whether stress may exacerbate autistic-like 
symptoms. Such research is crucial in the present, as stress is affecting both young and old which is 
resulting in more diseases and disorders. 
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Appendix 3: Serotonin Transporter ELISA Protocol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64 
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